EUVIMEDEUVIMED entdecken
Crossref

Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies

Dominika Oziębło iD, Natalia Bałdyga iD, Marcin L Leja iD, Adam Jarmuła iD, Tomasz Wilanowski iD, Henryk Skarżyński iD, Monika Ołdak iD

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Dominika Oziębło und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, Warsaw 02-042, Poland. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, Hearing Loss, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Science Centre, Institute of Physiology and Pathology of Hearing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The GRHL2 gene, encoding the Grainyhead-like 2 transcription factor, is essential for various biological processes. While GRHL2 has a complex role in cancer biology, its genetic variants have been also implicated in different forms of hearing loss (HL), including autosomal dominant non-syndromic hearing loss (DFNA28). Here, we report a novel c.1061C>T, p.(Ala354Val) mutation within the DNA binding domain (DBD) of GRHL2 that was identified in a three-generation HL family using a targeted multi-gene panel covering 237 HL-related genes. Unlike the previously reported DFNA28-causing variants that result in protein truncation, the impact of the p.(Ala354Val) missense change cannot be attributed to GRHL2 transcript level or composition, but to an alteration in protein function. Molecular dynamics simulations revealed destabilization of the p.(Ala354Val) mutant GRHL2 dimer interface and an altered DNA binding dynamics, leading to chaotic interaction patterns despite increased binding affinity to DNA. Functional assays demonstrated that the p.(Ala354Val) mutation and other DFNA28-related mutations in the DBD lead to loss of GRHL2 transcriptional transactivation activity, while the p.(Arg537Profs*11) mutation in the dimerization domain results in a gain-of-function effect. The findings indicate that both GRHL2 haploinsufficiency and gain-of-function contribute to HL and underscore the complex regulatory role of GRHL2 in maintaining proper function of the auditory system. Our study emphasizes the need to consider structural and functional aspects of gene variants to better understand their pathogenic potential. As GRHL2 is involved in a multitude of cellular processes, the data gathered here can be also applicable to other conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsDNA-Binding ProteinsHearing LossHearing Loss, SensorineuralHumansFemaleMalePedigreeMolecular Dynamics SimulationMutationMutation, MissenseAdult

Stichwörter der Autor:innen

DFNA28GRHL2gain of functionhaploinsufficiencyhearing losstransactivation activitytranscription

Substanzen

GRHL2 protein, humanTranscription FactorsDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, Warsaw 02-042, Poland.
  • Doctoral School of Translational Medicine, Centre of Postgraduate Medical Education, Marymoncka 99/103, Warsaw 01-813, Poland.
  • Faculty of Food Science, University of Warmia and Mazury in Olsztyn, M. Oczapowskiego 2, Olsztyn 10-719, Poland.
  • Faculty of Biology, Institute of Genetics and Biotechnology, University of Warsaw, I. Miecznikowa 1, Warsaw 02-096, Poland.
  • Oto-Rhino-Laryngology Surgery Clinic, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, Warsaw 02-042, Poland.

ORCID-Profile: Dominika Oziębło, Natalia Bałdyga, Marcin L Leja, Adam Jarmuła, Tomasz Wilanowski, Henryk Skarżyński, Monika Ołdak

Förderung

  • National Science Centre
  • Institute of Physiology and Pathology of Hearing

Zitieren

APA

Oziębło, D., Bałdyga, N., Leja, M. L., Jarmuła, A., Wilanowski, T., Skarżyński, H., & Ołdak, M. (2025). Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf013

Vancouver

Oziębło D, Bałdyga N, Leja ML, Jarmuła A, Wilanowski T, Skarżyński H, et al. Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf013

BibTeX
@article{Ozibo2025,
  author = {Oziębło, Dominika and Bałdyga, Natalia and Leja, Marcin L and Jarmuła, Adam and Wilanowski, Tomasz and Skarżyński, Henryk and Ołdak, Monika},
  title = {Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf013}
}
Kostenlos starten →